title: Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.
authors.forename: Marc C
authors.initials: MC
authors.lastname: Chamberlain
authors.forename: Andrew B
authors.initials: AB
authors.lastname: Lassman
authors.forename: Fabio M
authors.initials: FM
authors.lastname: Iwamoto
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D009364:Neoplasm Recurrence, Local; D011379:Prognosis
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab